Acorda Therapeutics Stock Price

-0.26 (-5.5%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.26 -5.5% 4.47 13:51:34
Open Price Low Price High Price Close Price Prev Close
4.23 4.19 4.65 4.73
Bid Price Ask Price Spread News
4.45 4.47 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,935 1,775,606 $ 4.44 $ 7,888,929 - 2.412 - 9.84
Last Trade Time Type Quantity Stock Price Currency
13:51:34 100 $ 4.47 USD


Draw Mode:

Acorda Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 49.73M 11.12M 10.95M $ 152.97M $ -143.12M -12.95 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 60.00k 5.80%

more financials information »

Acorda Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACOR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.686.363.574.7110,381,1040.7921.47%
1 Month5.166.363.574.702,842,491-0.69-13.37%
3 Months5.286.363.524.631,124,904-0.81-15.34%
6 Months7.518.153.524.94654,068-3.04-40.48%
1 Year4.689.842.4124.732,563,569-0.21-4.49%
3 Years145.50178.502.41219.401,805,385-141.03-96.93%
5 Years154.86218.102.41243.101,370,448-150.39-97.11%

Acorda Therapeutics Description

Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Your Recent History
Acorda The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.